Welcome back to Money Movers. Take a look at Novo today. Down double digits on pace for the worst day since 87 as the company cuts slashes really its fullear guidance.Novo saying that it now expects weaker growth expectations in the second half for GLP1 drugs WGOmpic. Company also announces the appointment of its incoming CEO Mike Dotstar effective August 7th. Joining us now to break down the move is Missouo healthcare equity strategist Jared Holtz.Jared, who writes, "Today, we believe analysts will start t ...